-+ 0.00%
-+ 0.00%
-+ 0.00%

THERAKOS DEVELOPMENT LTD: GETS MDR APPROVAL IN EUROPE TO TREAT IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS WITH INADEQUATE RESPONSE TO CORTICOSTEROIDS

Reuters·10/21/2026 18:03:40

Please log in to view news